首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Synthesis,cytotoxicity assessment,and interaction and docking of novel palladium(II) complexes of imidazole derivatives with human serum albumin
Authors:Mahboube Eslami Moghadam  Adeleh Divsalar  Abdolghafar Abolhosseini Shahrnoy  Ali Akbar Saboury
Institution:1. Chemistry &2. Chemical Engineering Research Center of Iran, Tehran, Iran;3. Faculty of Biological Sciences, Department of Cell &4. Molecular Biology, Kharazmi University, Tehran, Iran;5. Faculty of Sciences, Department of Chemistry, Tarbiat Modares University, Tehran 14115-175, Iran;6. Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
Abstract:Imidazole analogs are the agents that attract both bioinorganic chemist and drug designer. Numerous methods have been proposed for synthesis of imidazole derivatives. In this study, a series of heterocyclic system with p-conjugated system such as 2-aryl-imidazo4,5-f]1,10]phenanthroline analogs were synthesized. Then, three new palladium(II) complexes containing 2-(Furan-2-yl)-1H-Imidazo4,5-f]1,10]Phenanthroline (FIP) and 2-(thiophen-2-yl)-1H-imidazo4,5-f]1,10]phenanthroline (TIP) ligands were synthesized. The structures of the compounds, Pd(Phen)(TIP)](NO3)2, Pd(Phen)(FIP)](NO3)2, and Pd(FIP)2]Cl were determined by spectroscopic methods and elemental analysis. Biological activity of the complexes synthesized was assessed against chronic myelogenous leukemia cell line, K562. Also, the interactions of human serum albumin with complexes were investigated using isothermal titration in the Tris buffer, pH 7.4. According to the results obtained, it was found that there is a set of six binding sites for these complexes on HSA with positive cooperativity in the binding process. Docking technique was also applied to confirm the experimental results. The results showed that smaller complexes have higher interaction affinity.
Keywords:Pd(II) complex  imidazole derivative  HSA binding  docking  cytotoxicity
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号